Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study: Detection of Carcinomas Using 64Cu-Labeled M5A Antibody to Carcinoembryonic Antigen (CEA)

NCT02293954 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT02293954
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02293954 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study: Detection of Carcinomas Using 64Cu-Labeled M5A Antibody to Carcinoembryonic Antigen (CEA)
Lead sponsor
City of Hope Medical Center
Phase
Not applicable
Overall status
Active, not recruiting
Start date
November 11, 2015
Completion date
July 14, 2027
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, colon cancer, extrahepatic bile duct cancer, gallbladder cancer, gastrointestinal cancer, liver and intrahepatic biliary tract cancer, lung cancer, metastatic cancer, pancreatic cancer, rectal cancer, thyroid gland medullary carcinoma, unspecified adult solid tumor, protocol specific